These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23157294)

  • 1. Creation of catalytic antibodies metabolizing organophosphate compounds.
    Kurkova IN; Smirnov IV; Belogurov AA; Ponomarenko NA; Gabibov AG
    Biochemistry (Mosc); 2012 Oct; 77(10):1139-46. PubMed ID: 23157294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of enzymatic properties of DNA-abzymes and human DNAses.
    Baranovskii AG; Odintsova ES; Buneva VN; Doronin BM; Nevinsky GA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1053-6. PubMed ID: 15560102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents.
    Smirnov I; Belogurov A; Friboulet A; Masson P; Gabibov A; Renard PY
    Chem Biol Interact; 2013 Mar; 203(1):196-201. PubMed ID: 23123255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of a ribonuclease abzyme through site-directed mutagenesis.
    Fletcher MC; Kuderova A; Cygler M; Lee JS
    Nat Biotechnol; 1998 Nov; 16(11):1065-7. PubMed ID: 9831037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated catalysis: induction and therapeutic relevance.
    Mahendra A; Sharma M; Rao DN; Peyron I; Planchais C; Dimitrov JD; Kaveri SV; Lacroix-Desmazes S
    Autoimmun Rev; 2013 Apr; 12(6):648-52. PubMed ID: 23207286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of the Protective Properties of an Antibody-Based Antidote Metabolizing Organophosphorus Pesticide Paraoxon.
    Mokrushina YA; Stepanova AV; Palikov VA; Stepanov AV; Belous GI; Dyachenko IA; Knorre VD; Smirnov IV; Gabibov AG
    Bull Exp Biol Med; 2017 Jun; 163(2):218-221. PubMed ID: 28726199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in abzyme studies.
    Suzuki H
    J Biochem; 1994 Apr; 115(4):623-8. PubMed ID: 8089074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological tolerance to medical therapy of organophosphate poisoning and ways of tolerance management].
    Iudin MA; Bykov VN; Chepur SV; Sarana AM; Tsygan VN; Anokhin AG
    Voen Med Zh; 2014 May; 335(5):26-31. PubMed ID: 25286560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning.
    Masson P; Josse D; Lockridge O; Viguié N; Taupin C; Buhler C
    J Physiol Paris; 1998; 92(5-6):357-62. PubMed ID: 9789837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human catalytic RNA- and DNA-hydrolyzing antibodies.
    Nevinsky GA; Buneva VN
    J Immunol Methods; 2002 Nov; 269(1-2):235-49. PubMed ID: 12379364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
    Ghanem E; Raushel FM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered whole-cell biocatalyst-based detoxification and detection of neurotoxic organophosphate compounds.
    Kim CS; Seo JH; Kang DG; Cha HJ
    Biotechnol Adv; 2014; 32(3):652-62. PubMed ID: 24780157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment methods following suicidal self-administration of IV organophosphate: What can additional lipid administration change?
    Turkdogan KA; Duman A; Avcil M; Akoz A; Canakcı SE; Kantekin B
    Am J Emerg Med; 2017 Sep; 35(9):1388.e3-1388.e5. PubMed ID: 28711273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and characterization of lipase abzyme from phage displayed antibody libraries.
    Leong MK; Chen C; Shar KC; Shiuan D
    Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
    Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic bioscavengers as countermeasures against organophosphate nerve agents.
    Goldsmith M; Ashani Y
    Chem Biol Interact; 2018 Aug; 292():50-64. PubMed ID: 29990481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.